SEC Form D private-offering filing

Pelthos Therapeutics Inc.

Name: Pelthos Therapeutics Inc. - new SEC Form D private-offering filing, Durham, NC
Published: 2025-11-19

A new SEC Form D private-offering notice from Durham, NC, a $18,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Pelthos Therapeutics Inc. site↗ Verified via SEC Form D

Bio-pharmaceutical company commercializing FDA-approved dermatology treatments, including ZELSUVMI for molluscum contagiosum, formed via Ligand Pharmaceuticals' combination with Channel Therapeutics.

Filed 2025-11-19Filed to raise $18,000,000First money in 2025-11-06Raised so far $18,000,000HQ (as filed) Durham, NCSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified pelthos.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More new filings in North Carolina →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.